Melrilimab Uses, Dosage, Side Effects and more
Melrilimab is under investigation in clinical trial NCT03207243 (Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma).
| Trade Name | Melrilimab |
| Generic | Melrilimab |
| Melrilimab Other Names | Melrilimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
